Study brain structure in adults with muscle weakness
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study uses scans and other tests to understand how brain structure relates to symptoms in people with myotonic dystrophy type 1 or type 2. It may help researchers connect measurable brain changes to movement and other clinical outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 65 years old
- You have myotonic dystrophy type 1 or type 2 (DM1/DM2) based on genetic testing and/or approved clinical criteria
- If your diagnosis is based only on symptoms, you must have a first-degree relative with a positive DM1/DM2 genetic test
- You have signs of muscle weakness (for DM2: more in the upper/proximal muscles; for DM1: more in the lower/distal muscles)
- You can walk by yourself (a cane or walking stick is OK)
- You can follow study steps and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term follow-up for people with myotonic dystrophy type 1. It aims to find better ways to measure how the disease progresses, which could help develop future treatments.
This study looks for markers in spinal fluid that could help doctors better understand myotonic dystrophy type 1 (DM1). It involves a spinal tap and MRI scan. It may help people with DM1 and healthy volunteers learn more about the condition.
This study uses video calls and online assessments to track how myotonic dystrophy (a muscle-weakening condition) affects children over time. Researchers will also look at genetic factors to better understand the disease and improve care.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
This study measures physical and lab “health markers” in people with myotonic dystrophy type 1 (DM1) to better understand how the disease changes over time. Some participants may also have a muscle biopsy to study tissue differences.
This study follows people with myotonic dystrophy (DM1 or DM2) for 2 years to learn more about the disease. You must already be in the DM-Scope registry and have certain medical records available.
Hear when a new Myotonic Dystrophy Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.